Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 17, 2004
app pub date -
Aug 26, 2003
filing date -
Feb 26, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The invention relates to an interferon regulatory factor-1/human estrogen receptor fusion protein which is reversibly activatible by .beta.-estradiol and its use for treating carcinomas, particularly for treating hepatocellular carcinoma.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully